113 related articles for article (PubMed ID: 19671433)
1. Value of post-registration studies for reimbursement renewal.
Molimard M; Bamberger M; Vray M
Therapie; 2009; 64(3):203-13. PubMed ID: 19671433
[TBL] [Abstract][Full Text] [Related]
2. How to anticipate the assessment of the public health benefit of new medicines?
Massol J; Puech A; Boissel JP;
Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
[TBL] [Abstract][Full Text] [Related]
3. Relative added value: what are the tools to evaluate it?
Le Jeunne C; Woronoff-Lemsi MC; David N; de Sahb R;
Therapie; 2008; 63(2):113-7, 107-11. PubMed ID: 18561884
[TBL] [Abstract][Full Text] [Related]
4. Evaluation and validation of diagnostic tests for guiding therapeutic decisions.
Landais P; Méresse V; Ghislain JC
Therapie; 2009; 64(3):187-201. PubMed ID: 19671431
[TBL] [Abstract][Full Text] [Related]
5. Relative Added Value: What are the Tools to Evalue it?
Jeunne CL; Woronoff-Lemsi MC; David N; Sahb Rd;
Therapie; 2008; 63(2):113-7. PubMed ID: 27393729
[TBL] [Abstract][Full Text] [Related]
6. [Drug evaluation by the French National Health Authority for reimbursement decisions].
Bouvenot G
Bull Acad Natl Med; 2005 Nov; 189(8):1683-90; discussion 1690-1. PubMed ID: 16737094
[TBL] [Abstract][Full Text] [Related]
7. [Quantification of pharmacological progress by the French National Health Authorities].
Bouvenot G
Bull Acad Natl Med; 2006; 190(4-5):893-903; discussion 903-4. PubMed ID: 17195614
[TBL] [Abstract][Full Text] [Related]
8. How to best define target populations of medicines in view of their coverage by the national health insurance scheme?
Hamers FF; Massol J; Maillère P;
Therapie; 2010; 65(4):341-5, 335-9. PubMed ID: 20854757
[TBL] [Abstract][Full Text] [Related]
9. [State of unmet medical needs in France in 2006: necessity of reinforcing research effort].
Jouan-Flahault C; Billon N; Castaigne A; Henry YD; Omnes C; Puech A; Rosilio M; Lassale C
Therapie; 2007; 62(5):393-415. PubMed ID: 18206102
[TBL] [Abstract][Full Text] [Related]
10. Minimal requirements for test evaluation.
Magid E
Scand J Clin Lab Invest Suppl; 1997; 227():90-4. PubMed ID: 9127473
[TBL] [Abstract][Full Text] [Related]
11. A call for international harmonization in therapeutic risk management.
Hirst C; Cook S; Dai W; Perez-Gutthann S; Andrews E
Pharmacoepidemiol Drug Saf; 2006 Dec; 15(12):839-49; discussion 850-1. PubMed ID: 16981215
[TBL] [Abstract][Full Text] [Related]
12. [Immunization: process of elaborating guidelines and their evolution in France].
Floret D
Ann Pharm Fr; 2009 May; 67(3):219-23. PubMed ID: 19446673
[TBL] [Abstract][Full Text] [Related]
13. [The benefit provided by new medicinal products in 2005-2006--the viewpoint of the French National Authority for Health].
Bouvenot G
Therapie; 2007; 62(5):387-91. PubMed ID: 18206101
[TBL] [Abstract][Full Text] [Related]
14. Real medical benefit assessed by indirect comparison.
Falissard B; Zylberman M; Cucherat M; Izard V; Meyer F
Therapie; 2009; 64(3):225-32. PubMed ID: 19671436
[TBL] [Abstract][Full Text] [Related]
15. [The French National Authority for Health].
Degos L
Bull Acad Natl Med; 2006 Oct; 190(7):1327-37; discussion 1337-8. PubMed ID: 17450670
[TBL] [Abstract][Full Text] [Related]
16. Reimbursement for drugs -- a register study comparing economic outcome for five healthcare centres in areas with different socioeconomic conditions.
Semark B; Fredlund K; Astrand B; Brudin L
Scand J Public Health; 2009 Aug; 37(6):647-53. PubMed ID: 19546143
[TBL] [Abstract][Full Text] [Related]
17. [Assessment of actual benefits of new drugs by the Transparency Committee].
Le Jeunne C
J Fr Ophtalmol; 2008 Jan; 31(1):90-3. PubMed ID: 18401307
[TBL] [Abstract][Full Text] [Related]
18. Differential diagnostic test technology: sensitivity and specificity, an OIE validation perspective.
Schmitt B
Biologicals; 2005 Dec; 33(4):211-3. PubMed ID: 16289686
[TBL] [Abstract][Full Text] [Related]
19. [More openness about the registration of drugs in the Netherlands. College for the Review of Medicinal Products].
Konijnendijk A; Lekkerkerker JF
Ned Tijdschr Geneeskd; 1998 Jul; 142(28):1621-3. PubMed ID: 9763846
[TBL] [Abstract][Full Text] [Related]
20. [Access to medicines in France].
Bouvenot G; Bouvenot J
Bull Acad Natl Med; 2009 Mar; 193(3):649-59; discussion 659-62. PubMed ID: 19883016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
